Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P4HB | P07237 | 6/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 1.00 |
| ▸ | AKR1B1 | P15121 | 5/20 | 1.00 |
| ▸ | EPHX2 | P34913 | 5/20 | 1.00 |
| ▸ | GAA | P10253 | 4/20 | 1.00 |
| ▸ | POLB | P06746 | 3/20 | 1.00 |
| ▸ | MAPT | P10636 | 3/20 | 1.00 |
| ▸ | CA12 | O43570 | 3/20 | 1.00 |
| ▸ | CA2 | P00918 | 3/20 | 1.00 |
| ▸ | CA4 | P22748 | 3/20 | 1.00 |
| ▸ | CA7 | P43166 | 3/20 | 1.00 |
| ▸ | ALPL | P05186 | 2/20 | 1.00 |
| ▸ | ALPI | P09923 | 2/20 | 1.00 |
| ▸ | SLCO2B1 | O94956 | 2/20 | 1.00 |
| ▸ | MAOA | P21397 | 2/20 | 1.00 |
| ▸ | XDH | P47989 | 2/20 | 1.00 |
| ▸ | ADRA2C | P18825 | 1/20 | 1.00 |
| ▸ | NOX4 | Q9NPH5 | 1/20 | 1.00 |
| ▸ | KDM1A | O60341 | 1/20 | 1.00 |
| ▸ | HMGB1 | P09429 | 1/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Isoquercetin SCHEMBL15147267 | 1.00 | P4HB (1.00) | P4HBKDM4EAKR1B1EPHX2GAA | |
| Isoquercetin SCHEMBL2286562 | 1.00 | P4HB (1.00) | P4HBKDM4EAKR1B1EPHX2GAA | |
| Isoquercetin SCHEMBL12710506 | 1.00 | P4HB (1.00) | P4HBKDM4EAKR1B1EPHX2GAA | |
| Isoquercetin SCHEMBL6849311 | 1.00 | P4HB (1.00) | P4HBKDM4EAKR1B1EPHX2GAA | |
| Isoquercetin SCHEMBL561412 | 1.00 | P4HB (1.00) | P4HBKDM4EAKR1B1EPHX2GAA | |
| Isoquercetin SCHEMBL24609 | 1.00 | P4HB (1.00) | P4HBKDM4EAKR1B1EPHX2GAA | |
| Isoquercetin SCHEMBL19214052 | 1.00 | P4HB (1.00) | P4HBKDM4EAKR1B1EPHX2GAA | |
| Isoquercetin SCHEMBL21244358 | 1.00 | P4HB (1.00) | P4HBKDM4EAKR1B1EPHX2GAA | |
| Isoquercetin SCHEMBL22495101 | 1.00 | P4HB (1.00) | P4HBKDM4EAKR1B1EPHX2GAA | |
| Isoquercetin SCHEMBL672012 | 1.00 | P4HB (1.00) | P4HBKDM4EAKR1B1EPHX2GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 406 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250281451-A1 | COMPOSITIONS AND METHODS FOR MODULATING SLEEP AND USES THEREOF | BRIGHTSEED, INC. | 2025-09-11 | — | — | US | claimed |
| WO-2024112947-A1 | COMPOSITIONS AND METHODS FOR MODULATING SLEEP AND USES THEREOF | BRIGHTSEED, INC. (US) | 2024-05-30 | — | — | WO | claimed |
| US-11739113-B2 | Method for extracting and separating flavonoids from Lindera aggregata leaves | Ningbo Municipal Hospital of T.C.M. (CN) | 2023-08-29 | — | — | US | claimed |
| US-20230147050-A1 | Method For Extracting And Separating Flavonoids From Lindera Aggregata Leaves | Ningbo Municipal Hospital of T.C.M. (CN) | 2023-05-11 | — | — | US | claimed |
| EP-4144217-A1 | ANTIMICROBIAL COMPOSITION FOR HARD SURFACES | Viraschutz Europe S.r.l. (IT) | 2023-03-08 | — | — | EP | claimed |
| US-20220098418-A1 | CURABLE COATING COMPOSITIONS AND ANTIMICROBIAL COATINGS MADE BY CURING SUCH COATING COMPOSITIONS | GREEN THEME TECHNOLOGIES, INC. | 2022-03-31 | — | — | US | claimed |
| CN-110615821-A | Mulberry extract, extraction and separation method and application thereof | 西北大学 | 2019-12-27 | — | — | CN | claimed |
| CN-106046081-B | The preparation and application of flavonoid glycoside active component in a kind of polygonum capitatum | 浙江大学 | 2019-05-21 | — | — | CN | claimed |
| US-9381223-B2 | Methods for inhibiting advanced glycation end product production, inhibiting fibroblast apoptosis, and/or promoting human fibroblast-collagen grating formulation using cherry blossom and cherry leaf extract | ORYZA OIL & FAT CHEMICAL CO., LTD. (JP) | 2016-07-05 | — | — | US | claimed |
| US-20150190369-A1 | QUERCETIN-3-GLUCOSIDE AND USES THEREOF | MBIKAY MAJAMBU (CA) | 2015-07-09 | — | — | US | claimed |
| WO-2008032105-A2 | FLAVONOID DERIVATIVES AND THEIR USES | THE BABRAHAM INSTITUTE (GB) | 2008-03-20 | — | — | WO | claimed |
| EP-1814559-A1 | METHODS AND COMPOSITIONS FOR PROTECTING CELLS FROM ULTRASOUND-MEDIATED CYTOLYSIS | GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2007-08-08 | — | — | EP | claimed |
| CN-1978452-A | New process for preparing isoquercitrin | UNIV XINJIANG MEDICAL (CN) | 2007-06-13 | — | — | CN | claimed |
| WO-2006090206-A1 | IMPROVED EXTRACTS OF PSIDIUM GUAJAVA L., METHODS FOR ITS OBTAINING AND USE FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS | LOZOYA LEGORRETA XAVIER (MX) | 2006-08-31 | — | — | WO | claimed |
| WO-2006045050-A1 | METHODS AND COMPOSITIONS FOR PROTECTING CELLS FROM ULTRASOUND-MEDIATED CYTOLYSIS | THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by the SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, NATIONAL INSTITUTES OF HEALTH (US) | 2006-04-27 | — | — | WO | claimed |
| EP-1649761-A1 | Composition for the treatment of chronic venous insufficiencies comprising an extract of red vine leaves | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2006-04-26 | — | — | EP | claimed |
| EP-1300084-B1 | Composition for the treatment of chronic venous insufficiencies comprising an extract of red vine leaves | BOEHRINGER INGELHEIM INT (DE) | 2006-04-19 | — | — | EP | claimed |
| EP-1300084-A2 | Composition for the treatment of chronic venous insufficiencies comprising an extract of red vine leaves | BOEHRINGER INGELHEIM INTERNATIONAL GmbH (DE) | 2003-04-09 | — | — | EP | claimed |
| EP-1225810-B1 | METHOD FOR TREATMENT OF CHRONIC VENOUS INSUFFICIENCIES USING AN EXTRACT OF RED VINE LEAVES | BOEHRINGER INGELHEIM INT (DE) | 2003-03-26 | — | — | EP | claimed |
| WO-2001003687-A2 | METHOD AND COMPOSITIONS FOR INHIBITING BIOSYNTHESIS OR BIOACTIVITY OF ENDOGENOUS STEROID SEX HORMONES IN HUMANS | CEDARS-SINAI MEDICAL CENTER (US) | 2001-01-18 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250281451-A1 | COMPOSITIONS AND METHODS FOR MODULATING SLEEP AND USES THEREOF | PER2, PYGB, CRY2 | P4HB 4412/4885KDM4E 256/4885AKR1B1 4602/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.